Peregrine Pharmaceuticals Inc.

Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010.(Financial report)
Cancer Weekly; 12/22/2009; 1825 words; Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) announced financial results for the...wholly owned contract manufacturing subsidiary (see also Peregrine Pharmaceuticals, Inc.). Avid generated manufacturing revenue of $5,308...

Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results.(Financial report)
Biotech Week; 12/16/2009; 682 words; Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM...Peregrine Pharmaceuticals, Inc.). Peregrine's...Investment, Peregrine Pharmaceuticals, Pharmaceutical Business, Pharmaceutical...Peregrine Pharmaceuticals Inc. This article was...

Peregrine Completes Patient Enrollment in Cotara Dose Confirmation and Dosimetry Brain Cancer Trial.
Cancer Weekly; 12/15/2009; 1360 words; Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) reported...Peregrine Pharmaceuticals, Inc.). In the ongoing...Oncology, Peregrine Pharmaceuticals, Pharmaceutical Business, Pharmaceutical...Peregrine Pharmaceuticals Inc

United States : Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript.(Financial report)
TendersInfo; 12/12/2009; 671 words; ...Byline: Mamta03 Welcome to the Peregrine Pharmaceuticals second quarter fiscal 2010...call with the management of Peregrine Pharmaceuticals. We re here...Head of Regulatory Affairs of Peregrine, as well as Chris Eso, Vice...

United States : Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010.(Financial report)
TendersInfo; 12/11/2009; 883 words; Byline: datta03 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced...customers during the quarter. Peregrine also generated revenue from services...the reduced resource needs of Peregrine's current clinical programs...